Abstract:Drug repositioning is a strategy of repurposing approved drugs for treating new indications, which can accelerate the drug discovery process, reduce development costs, and lower the safety risk. The advancement of biotechnology has significantly accelerated the speed and scale of biological data generation, offering significant potential for drug repositioning through biomedical knowledge graphs that integrate diverse entities and relations from various biomedical sources. To fully learn the semantic information and topological structure information from the biological knowledge graph, we propose a knowledge graph convolutional network with a heuristic search, named KGCNH, which can effectively utilize the diversity of entities and relationships in biological knowledge graphs, as well as topological structure information, to predict the associations between drugs and diseases. Specifically, we design a relation-aware attention mechanism to compute the attention scores for each neighboring entity of a given entity under different relations. To address the challenge of randomness of the initial attention scores potentially impacting model performance and to expand the search scope of the model, we designed a heuristic search module based on Gumbel-Softmax, which uses attention scores as heuristic information and introduces randomness to assist the model in exploring more optimal embeddings of drugs and diseases. Following this module, we derive the relation weights, obtain the embeddings of drugs and diseases through neighborhood aggregation, and then predict drug-disease associations. Additionally, we employ feature-based augmented views to enhance model robustness and mitigate overfitting issues. We have implemented our method and conducted experiments on two data sets. The results demonstrate that KGCNH outperforms competing methods. In particular, case studies on lithium and quetiapine confirm that KGCNH can retrieve more actual drug-disease associations in the top prediction results.

KG-Predict: A knowledge graph computational framework for drug repurposing

Knowledge-driven drug repurposing using a comprehensive drug knowledge graph

EKGDR: An End-to-End Knowledge Graph-Based Method for Computational Drug Repurposing

KGML-xDTD: a knowledge graph–based machine learning framework for drug treatment prediction and mechanism description

Knowledge Graphs for drug repurposing: a review of databases and methods

KGML-xDTD: A Knowledge Graph-based Machine Learning Framework for Drug Treatment Prediction and Mechanism Description

A Multimodal Framework for Improving in Silico Drug Repositioning with the Prior Knowledge from Knowledge Graphs

SynDRep: A Knowledge Graph-Enhanced Tool based on Synergistic Partner Prediction for Drug Repurposing

Knowledge Graph Convolutional Network with Heuristic Search for Drug Repositioning

KG-DTI: a Knowledge Graph Based Deep Learning Method for Drug-Target Interaction Predictions and Alzheimer's Disease Drug Repositions.

RareDR: A Drug Repositioning Approach for Rare Diseases Based on Knowledge Graph.

HeteroKGRep: Heterogeneous Knowledge Graph based Drug Repositioning

KG-DTI: a knowledge graph based deep learning method for drug-target interaction predictions and Alzheimer’s disease drug repositions

Biomedical knowledge graph learning for drug repurposing by extending guilt-by-association to multiple layers

Drug Repurposing using Consilience of Knowledge Graph Completion Methods

RDKG-115: Assisting drug repurposing and discovery for rare diseases by trimodal knowledge graph embedding

Learning a Patent-Informed Biomedical Knowledge Graph Reveals Technological Potential of Drug Repositioning Candidates

Drug repositioning based on the heterogeneous information fusion graph convolutional network

A knowledge graph approach to drug repurposing for Alzheimer's, Parkinson's and Glioma using drug-disease-gene associations

HGDD - A Drug-Disease High-Order Association Information Extraction Method for Drug Repurposing via Hypergraph.

Understanding the Performance of Knowledge Graph Embeddings in Drug Discovery